autosampler (model 717 plus) (Shimadzu Corporation)
Shimadzu Corporation is a verified supplier 
Shimadzu Corporation manufactures this product 
90
Structured Review
Shimadzu Corporation
autosampler (model 717 plus)
Autosampler (Model 717 Plus), supplied by Shimadzu Corporation, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/autosampler+(model+717+plus)/uv+vis+spectrophotomet/pm34051251-61-47-37
Average 90 stars, based on 1 article reviews
Autosampler (Model 717 Plus), supplied by Shimadzu Corporation, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/autosampler+(model+717+plus)/uv+vis+spectrophotomet/pm34051251-61-47-37
Average 90 stars, based on 1 article reviews
autosampler (model 717 plus) - by Bioz Stars,
2026-10
90/100 stars
Images
Related Articles
Solvent:Article Title: Novel Bioequivalent Tablet of Solifenacin Succinate Prepared Using Direct Compression Technique for Improved Chemical Stability. Article Snippet: .. Ten tablets were immersed in a mixture of methanol and ACN (4:3, v/v; 100 mL), and the drug was dissolved in the solvent via bath sonication for 1 h. After centrifugation, the supernatant was diluted via the mobile phase and injected into a Sonication:Article Title: Novel Bioequivalent Tablet of Solifenacin Succinate Prepared Using Direct Compression Technique for Improved Chemical Stability. Article Snippet: .. Ten tablets were immersed in a mixture of methanol and ACN (4:3, v/v; 100 mL), and the drug was dissolved in the solvent via bath sonication for 1 h. After centrifugation, the supernatant was diluted via the mobile phase and injected into a Centrifugation:Article Title: Novel Bioequivalent Tablet of Solifenacin Succinate Prepared Using Direct Compression Technique for Improved Chemical Stability. Article Snippet: .. Ten tablets were immersed in a mixture of methanol and ACN (4:3, v/v; 100 mL), and the drug was dissolved in the solvent via bath sonication for 1 h. After centrifugation, the supernatant was diluted via the mobile phase and injected into a Article Title: Montelukast microsuspension with hypromellose for improved stability and oral absorption. Article Snippet: International Journal of Biological Macromolecules 183 (2021) 1732–1742 Contents lists available at ScienceDirect International Journal of Biological Macromolecules j ourna l homepage: ht tp : / /www.e lsev ie r .com/ locate / i j b iomac Montelukast microsuspension with hypromellose for improved stability and oral absorption Ha Ryeong Lee a, Hyun Jin Park a, Jun Soo Park a, Dong Woo Park a, Myoung Jin Ho a, Dong Yoon Kim a, Hyo Chun Lee a, Eun Jeong Kim b, Woo Heon Song a, Jun Sang Park b, Yong Seok Choi a, Myung Joo Kang a,⁎ a College of Pharmacy, Dankook University, 119 Dandae-ro, Dongnam-gu, Cheonan, Chungnam 330-714, Republic of Korea b GL Pharm Tech Corp., 137, Sagimakgol-ro, Jungwon-gu, Seongnam, Republic of Korea ⁎ Corresponding author.. E-mail address: kangmj@dankook.ac.kr (M.J. Kang). https://doi.org/10.1016/j.ijbiomac.2021.05.151 0141-8130/© 2021 Elsevier B.V. All rights reserved. a b s t r a c t a r t i c l e i n f o Article history: Received 2 March 2021 Received in revised form 14 May 2021 Accepted 23 May 2021Available online 27 May 2021 Keywords: Montelukast Hypromellose Microsuspension Stability Crystallinity Pharmacokinetics Oralmontelukast (MTK) is prescribed to treat asthma or rhinitis, and is clinically investigated as newmedication in the treatment of Alzheimer's dementia.. Herein, in order to better patient's compliance, microsuspensions (MSs)-based oral liquid preparations of montelukast (MTK) were formulatedwith polymeric suspending agents including hypromellose (HPMC), and those drug-polymer interaction, physicochemical stability, dissolution, and in vivo pharmacokinetic profile was evaluated. Injection:Article Title: Novel Bioequivalent Tablet of Solifenacin Succinate Prepared Using Direct Compression Technique for Improved Chemical Stability. Article Snippet: .. Ten tablets were immersed in a mixture of methanol and ACN (4:3, v/v; 100 mL), and the drug was dissolved in the solvent via bath sonication for 1 h. After centrifugation, the supernatant was diluted via the mobile phase and injected into a High Performance Liquid Chromatography:Article Title: Novel Bioequivalent Tablet of Solifenacin Succinate Prepared Using Direct Compression Technique for Improved Chemical Stability. Article Snippet: .. Ten tablets were immersed in a mixture of methanol and ACN (4:3, v/v; 100 mL), and the drug was dissolved in the solvent via bath sonication for 1 h. After centrifugation, the supernatant was diluted via the mobile phase and injected into a Article Title: Montelukast microsuspension with hypromellose for improved stability and oral absorption. Article Snippet: International Journal of Biological Macromolecules 183 (2021) 1732–1742 Contents lists available at ScienceDirect International Journal of Biological Macromolecules j ourna l homepage: ht tp : / /www.e lsev ie r .com/ locate / i j b iomac Montelukast microsuspension with hypromellose for improved stability and oral absorption Ha Ryeong Lee a, Hyun Jin Park a, Jun Soo Park a, Dong Woo Park a, Myoung Jin Ho a, Dong Yoon Kim a, Hyo Chun Lee a, Eun Jeong Kim b, Woo Heon Song a, Jun Sang Park b, Yong Seok Choi a, Myung Joo Kang a,⁎ a College of Pharmacy, Dankook University, 119 Dandae-ro, Dongnam-gu, Cheonan, Chungnam 330-714, Republic of Korea b GL Pharm Tech Corp., 137, Sagimakgol-ro, Jungwon-gu, Seongnam, Republic of Korea ⁎ Corresponding author.. E-mail address: kangmj@dankook.ac.kr (M.J. Kang). https://doi.org/10.1016/j.ijbiomac.2021.05.151 0141-8130/© 2021 Elsevier B.V. All rights reserved. a b s t r a c t a r t i c l e i n f o Article history: Received 2 March 2021 Received in revised form 14 May 2021 Accepted 23 May 2021Available online 27 May 2021 Keywords: Montelukast Hypromellose Microsuspension Stability Crystallinity Pharmacokinetics Oralmontelukast (MTK) is prescribed to treat asthma or rhinitis, and is clinically investigated as newmedication in the treatment of Alzheimer's dementia.. Herein, in order to better patient's compliance, microsuspensions (MSs)-based oral liquid preparations of montelukast (MTK) were formulatedwith polymeric suspending agents including hypromellose (HPMC), and those drug-polymer interaction, physicochemical stability, dissolution, and in vivo pharmacokinetic profile was evaluated. Concentration Assay:Article Title: Montelukast microsuspension with hypromellose for improved stability and oral absorption. Article Snippet: International Journal of Biological Macromolecules 183 (2021) 1732–1742 Contents lists available at ScienceDirect International Journal of Biological Macromolecules j ourna l homepage: ht tp : / /www.e lsev ie r .com/ locate / i j b iomac Montelukast microsuspension with hypromellose for improved stability and oral absorption Ha Ryeong Lee a, Hyun Jin Park a, Jun Soo Park a, Dong Woo Park a, Myoung Jin Ho a, Dong Yoon Kim a, Hyo Chun Lee a, Eun Jeong Kim b, Woo Heon Song a, Jun Sang Park b, Yong Seok Choi a, Myung Joo Kang a,⁎ a College of Pharmacy, Dankook University, 119 Dandae-ro, Dongnam-gu, Cheonan, Chungnam 330-714, Republic of Korea b GL Pharm Tech Corp., 137, Sagimakgol-ro, Jungwon-gu, Seongnam, Republic of Korea ⁎ Corresponding author.. E-mail address: kangmj@dankook.ac.kr (M.J. Kang). https://doi.org/10.1016/j.ijbiomac.2021.05.151 0141-8130/© 2021 Elsevier B.V. All rights reserved. a b s t r a c t a r t i c l e i n f o Article history: Received 2 March 2021 Received in revised form 14 May 2021 Accepted 23 May 2021Available online 27 May 2021 Keywords: Montelukast Hypromellose Microsuspension Stability Crystallinity Pharmacokinetics Oralmontelukast (MTK) is prescribed to treat asthma or rhinitis, and is clinically investigated as newmedication in the treatment of Alzheimer's dementia.. Herein, in order to better patient's compliance, microsuspensions (MSs)-based oral liquid preparations of montelukast (MTK) were formulatedwith polymeric suspending agents including hypromellose (HPMC), and those drug-polymer interaction, physicochemical stability, dissolution, and in vivo pharmacokinetic profile was evaluated. |